521 related articles for article (PubMed ID: 16886957)
21. Low dose growth hormone treatment in infants and toddlers with Prader-Willi syndrome is comparable to higher dosage regimens.
Scheermeyer E; Harris M; Hughes I; Crock PA; Ambler G; Verge CF; Bergman P; Werther G; Craig ME; Choong CS; Davies PSW;
Growth Horm IGF Res; 2017 Jun; 34():1-7. PubMed ID: 28427039
[TBL] [Abstract][Full Text] [Related]
22. Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment.
Festen DA; Visser TJ; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2007 Sep; 67(3):449-56. PubMed ID: 17716335
[TBL] [Abstract][Full Text] [Related]
23. Sleep cycling alternating pattern (CAP) expression is associated with hypersomnia and GH secretory pattern in Prader-Willi syndrome.
Priano L; Grugni G; Miscio G; Guastamacchia G; Toffolet L; Sartorio A; Mauro A
Sleep Med; 2006 Dec; 7(8):627-33. PubMed ID: 17023209
[TBL] [Abstract][Full Text] [Related]
24. The efficacy and safety of long-term Norditropin® treatment in children with Prader-Willi syndrome.
Meinhardt U; Christiansen JS; Farholt S; Lämmer C; Ostergaard JR; Schmidt F; Kappelgaard AM; Eiholzer U
Horm Metab Res; 2013 Jul; 45(7):532-6. PubMed ID: 23632904
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
Cutfield WS; Lundgren F
Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone and body composition in children younger than 2 years with Prader-Willi syndrome.
Eiholzer U; L'allemand D; Schlumpf M; Rousson V; Gasser T; Fusch C
J Pediatr; 2004 Jun; 144(6):753-8. PubMed ID: 15192622
[TBL] [Abstract][Full Text] [Related]
27. Analysis of NREM sleep in children with Prader-Willi syndrome and the effect of growth hormone treatment.
Verrillo E; Bruni O; Franco P; Ferri R; Thiriez G; Pavone M; Petrone A; Paglietti MG; Crinò A; Cutrera R
Sleep Med; 2009 Jun; 10(6):646-50. PubMed ID: 19027358
[TBL] [Abstract][Full Text] [Related]
28. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone induced lipolysis during short- and long-term administration in adult Prader-Willi patients.
Höybye C; Hilding A; Marcus C; Thorén M
Growth Horm IGF Res; 2005 Dec; 15(6):411-5. PubMed ID: 16230042
[TBL] [Abstract][Full Text] [Related]
30. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA
J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
[TBL] [Abstract][Full Text] [Related]
32. Association between foot growth and musculoskeletal loading in children with Prader-Willi syndrome before and during growth hormone treatment.
Eiholzer U; Meinhardt U; Gallo C; Schlumpf M; Rousson V; l'Allemand D
J Pediatr; 2009 Feb; 154(2):225-9. PubMed ID: 18822426
[TBL] [Abstract][Full Text] [Related]
33. Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome.
Miller J; Silverstein J; Shuster J; Driscoll DJ; Wagner M
J Clin Endocrinol Metab; 2006 Feb; 91(2):413-7. PubMed ID: 16317059
[TBL] [Abstract][Full Text] [Related]
34. Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS data.
Reinehr T; Bechtold-Dalla Pozza S; Bettendorf M; Doerr HG; Gohlke B; Hauffa BP; Kaspers S; Land C; Mehls O; Schwab KO; Stahnke N; Ranke MB;
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):544-8. PubMed ID: 22006181
[TBL] [Abstract][Full Text] [Related]
35. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
[TBL] [Abstract][Full Text] [Related]
36. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone.
Rachmiel M; Rota V; Atenafu E; Daneman D; Hamilton J
Horm Res; 2007; 68(5):236-43. PubMed ID: 17396034
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone responsiveness: peak stimulated growth hormone levels and other variables in idiopathic short stature (ISS): data from the National Cooperative Growth Study.
Moore WV; Dana K; Frane J; Lippe B
Pediatr Endocrinol Rev; 2008 Sep; 6(1):5-8. PubMed ID: 18806719
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone treatment for short stature in children born small for gestational age.
Jung H; Rosilio M; Blum WF; Drop SL
Adv Ther; 2008 Oct; 25(10):951-78. PubMed ID: 18836868
[TBL] [Abstract][Full Text] [Related]
39. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
Höybye C; Thorén M; Böhm B
J Intellect Disabil Res; 2005 Apr; 49(Pt 4):245-52. PubMed ID: 15816811
[TBL] [Abstract][Full Text] [Related]
40. Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome.
Festen DA; Wevers M; Lindgren AC; Böhm B; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Jun; 68(6):919-25. PubMed ID: 18031326
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
